Takeda to Hold Fourth Quarter and Full-Year FY2020 Earnings Conference Calls
Takeda Manufacturing Facilities in Japan and Ireland Recognized With Category Awards for 2021 Facilities of the Year
Takeda Announces U.S. FDA Grants Priority Review for New Drug Application for Mobocertinib (TAK-788) as a Treatment for EGFR Exon20 Insertion+ Metastatic Non-Small Cell Lung Cancer
CoVIg-19 Plasma Alliance Announces Topline Results from NIH-Sponsored Clinical Trial of Investigational COVID-19 Hyperimmune Globulin Medicine
Takeda Hosts Wave 1 Pipeline Market Call
SEE ALL NEWS AND RELEASES >
・For Shire news releases, click here
Understanding the Role of Orexin in Sleep and Wakefulness
Exploring New Paths in Narcolepsy
Spotlight Malawi: Many Paths Towards Universal Health Coverage and a Strong Health Workforce
Guided by Our Values: Supporting Global COVID-19 Response
A ‘Swiss Cheese’ Approach Can Give Us a Second Chance to Contain COVID-19
SEE ALL FEATURED TOPICS ARTICLES >
With this new original series featured in Asahi Shimbun Globe, President & CEO Christophe Weber gives his unique perspective on what he has learned from his upbringing in France and his international career.
For media inquiries or reporter requests for more information, contact our Corporate Communications via Media_Relations@takeda.com. If you generally would like to contact us, please visit Contact Us.
Copyright 1995-2021 Takeda Pharmaceutical Company Limited. All rights reserved.